BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1238498)

  • 1. Effect of gestagen therapy upon 17beta-hydroxysteroid dehydrogenase in human endometrial adenocarcinoma.
    Pollow K; Boquoi E; Lübbert H; Pollow B
    J Endocrinol; 1975 Oct; 67(1):131-2. PubMed ID: 1238498
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of gestagen therapy upon estradiol- and progesterone-receptor-level and 17beta-hydroxysteroid dehydrogenase in human endometrial adenocarcinoma (author's transl)].
    Pollow K; Boquoi E
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Aug; 86(3):231-42. PubMed ID: 185824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localization of estradiol 17beta dehydrogenase in human endometrium.
    Scublinsky A; Marin C; Gurpide E
    J Steroid Biochem; 1976 Oct; 7(10):745-7. PubMed ID: 1011831
    [No Abstract]   [Full Text] [Related]  

  • 4. On the mitochondrial 17beta-hydroxysteroid dehydrogenase from human endometrium and endometrial carcinoma: characterization and intramitochondrial distribution.
    Pollow K; Lübbert H; Pollow B
    J Steroid Biochem; 1976 Jan; 7(1):45-50. PubMed ID: 5632
    [No Abstract]   [Full Text] [Related]  

  • 5. Estradiol receptor and 17 beta-dehydrogenase in normal and abnormal human endometrium.
    Tseng L; Gusberg SB; Gurpide E
    Ann N Y Acad Sci; 1977 Mar; 286():190-8. PubMed ID: 281172
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adjuvant gestagen therapy of endometrial carcinoma (author's transl)].
    Bochmann JW
    Zentralbl Gynakol; 1981; 103(21):1289-93. PubMed ID: 7324631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial purification and evidence for heterogeneity of the cytoplasmic 17beta-hydroxysteroid dehydrogenase (17beta-HSD) from normal human endometrium and endometrical carcinoma.
    Pollow K; Lübbert H; Pollow B
    J Steroid Biochem; 1976 Apr; 7(4):315-20. PubMed ID: 933531
    [No Abstract]   [Full Text] [Related]  

  • 8. The influence of progesterone caproate on the enzyme profile of endometrial carcinoma.
    Thiery M; Willighagen RG
    Bull Soc R Belge Gynecol Obstet; 1968; 38(1):1-5. PubMed ID: 5746432
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on 17beta-hydroxysteroid dehydrogenase in human endometrium and endometrial carcinoma.
    Pollow K; Lübbert H; Jeske R; Pollow B
    Acta Endocrinol (Copenh); 1975 May; 79(1):146-56. PubMed ID: 236629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapy of adenocarcinoma of the endometrium with synthetic progestogens].
    Lanza A; Fedele M; Renzetti ME; Ferraris G
    Minerva Ginecol; 1981 Oct; 33(10):917-36. PubMed ID: 7031519
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of the results of gestagen therapy of cancer of the corpus uteri with a preliminary study of tumor cell culture sensitivity to the preparations].
    Schindler C; Pavlovich T
    Vopr Onkol; 1982; 28(3):52-6. PubMed ID: 7064419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of human endometrial estradiol dehydrogenase by progestins.
    Tseng L; Gurpide E
    Endocrinology; 1975 Oct; 97(4):825-33. PubMed ID: 172318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal PRs mediate induction of 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrial epithelium: a paracrine mechanism for inactivation of E2.
    Yang S; Fang Z; Gurates B; Tamura M; Miller J; Ferrer K; Bulun SE
    Mol Endocrinol; 2001 Dec; 15(12):2093-105. PubMed ID: 11731611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on 17beta-hydroxysteroid dehydrogenase in human endometrium and endometrial carcinoma I. Subcellular distribution and variations of specific enzyme activity.
    Polow K; Lübbert H; Boquoi E; Kreutzer G; Jeske R; Pollow B
    Acta Endocrinol (Copenh); 1975 May; 79(1):134-45. PubMed ID: 1173301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regularities and paradoxes of endocrine dependence and hormonal therapy of endometrial cancer].
    Bokhman IaV; Volkova AT; Chepik OF; Vishnevskiĭ AS
    Vopr Onkol; 1990; 36(11):1382-8. PubMed ID: 2281650
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hormonal transformation characteristics of endometrial adenoacanthoma in the process of progestin treatment].
    Shenderëva TS; Shvedova LA
    Vopr Onkol; 1981; 27(10):52-6. PubMed ID: 7303557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fundamentals of progesterone therapy of endometrial carcinoma].
    Minerva Med; 1978 Nov; 69(58):3986-91. PubMed ID: 740291
    [No Abstract]   [Full Text] [Related]  

  • 18. [Progesterone and progestagens in the treatment of endometrial cancers. Apropos of a personal case].
    Giraud B; Dauplat J
    J Gynecol Obstet Biol Reprod (Paris); 1974; 3(7):1063-74. PubMed ID: 4470770
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of progestins on the ultrastructure of endometrial cells in pretumorous changes and cancer (an organ-culture study)].
    Beliaeva LA; Bukhvalov IB; Zheleznov BI; Raĭkhlin NT
    Arkh Patol; 1982; 44(4):18-25. PubMed ID: 7082195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A histochemical study of the effect of progesterone on the carbohydrate metabolism enzymes of different morphologic forms of endometrial cancer].
    Prianishnikov VA; Bokhman IaV; Chepik OF
    Arkh Patol; 1975; 37(6):19-23. PubMed ID: 176978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.